During the past decade, Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials, followed by "Medtronic Vascular" with 3 trials sponsored, "Biotronik SE & Co. KG" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s" #1 collaborator was "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials as a collaborator, "Medstar Health Research Institute" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator, "Qmed Consulting A/S" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s" are "Coronary Artery Disease" (5 trials), "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s" in a lesser frequency.

Most popular intervention types in "Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s" are "Device" (10 trials), "Drug" (5 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Angio guided CABG" (1 trials) and "BioMonitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".